Results 131 to 140 of about 729,299 (226)

Immunological characterization of plasminogen activator activities in human tissues and body fluids

, 1981
Human plasminogen activators were compared immunologically in both a double-diffusion technique and quenching experiments on the fibrinolytic activities of the activators.
Rijken, D.C., Wijngaards, G., Welbergen, J.   +2 more
core  

suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D. [PDF]

Diabetes Care
Ismail A, Huang Y, Ghazzal B, Hutten C, Farhat T, Elangovan R, Bobby B, Kunkle P, Vasbinder A, Banerjee M, Quyyumi A, Pratley RE, Brooks MM, Pop-Busui R, Hayek SS.   +14 more
europepmc   +1 more source

Identification of Urokinase Plasminogen Activator Receptor (uPAR)-Binding Peptides Using Phage Display: Strategy and Downstream Validation. [PDF]

Cancers (Basel)
Sloth AB, Dawoodi IM, Treiberg T, Sinkjaer AW, Andersen IV, Andersen AO, Bøgestad ECS, Rossing M, Stavnsbjerg C, Bakhshinejad B, Kjaer A.   +10 more
europepmc   +1 more source

Association of the inflammatory marker suPAR with chronic pruritus of unknown origin - data from the SOMA.PRU study. [PDF]

Front Immunol
Kahnert SM, Jürgens L, Dreher L, Schmidt-Lauber C, Koechel A, Frank GL, Huber TB, Shedden-Mora M, Ständer S, Ramm M, Schneider G, Conrad R.   +11 more
europepmc   +1 more source

Biomarkers of systemic disease burden and outcomes after transcatheter tricuspid edge-to-edge repair. [PDF]

BMC Cardiovasc Disord
Schlegl J, Bannehr M, Lichtenauer M, Kücken T, Krutz A, Paar V, Neuß M, Haase-Fielitz A, Butter C, Edlinger C.   +9 more
europepmc   +1 more source

Combining biomarkers with clinical risk factors to predict acute kidney injury after cardiopulmonary bypass surgery: An observational cohort study. [PDF]

Medicine (Baltimore)
Xu X, Liang Y, Shi S, Si H, Cheng A, Wang J, Liu T, Wang H, Hu J.   +8 more
europepmc   +1 more source

Plasminogen Activation System and Fibroblasts: Impact on Tissue Remodeling, Disease, and Organ Homeostasis. [PDF]

Inflammation
Moideen FM, Bhandary YP.
europepmc   +1 more source

Beyond Fibrinolysis: Urokinase Plasminogen Activator as an Early Regulator of Obesity. [PDF]

Arterioscler Thromb Vasc Biol
Torrente D, Strickland S.
europepmc   +1 more source

Potential Role of the Urokinase-Type Plasminogen Activator Receptor-Integrin β3 Axis in Podocyte Adhesion Instability and Loss. [PDF]

Kidney Int Rep
Kim JH, Dang BTN, Kim J, Eom M, Cha SK, Kim J.   +5 more
europepmc   +1 more source

Polypeptide inhibitors of urokinase type plasminogen activator

A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminigen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Winter, Greg, Angelini, Alessandro, Heinis, Christian   +2 more
core